|drug3269||Stem Cell Educator-Treated Mononuclear Cells Apheresis Wiki||1.00|
There is one clinical trial.
Comparing the efficacy of add on therapy of Ivermectin in covid19 patients to non ivermermectin group
Description: Number of patients cured assessed by Nasopharyngeal swab, oropharyngeal swab, and blood aspiration for covid19 (PCR) in addtion to Chest xaryMeasure: Number of cured patients Time: 4 weeks
Description: comparing mean time of cure of patients in IVM group with the the non IVM groupMeasure: Mean time to cure of the covid 19 patients Time: 4 week
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports